academic article

• APOE3.  The New England journal of medicine.  390:2156-2164. 2024
• Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:4127-4138. 2023
• Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man..  Nature medicine.  29:1243-1252. 2023
• Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia..  Acta neuropathologica.  144:589-601. 2022
• Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:169-180. 2022
• Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease..  Journal of Alzheimer's disease : JAD.  88:721-729. 2022
• Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer's disease..  Brain communications.  3:-. 2021
• The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America..  EClinicalMedicine.  -. 2021
• Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study..  Alzheimer's research & therapy.  13:-. 2021
• Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease..  Journal of Alzheimer's disease : JAD.  82:1809-1822. 2021